Evidence map›Paper›PMID 23980208›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model.

Kristin Hollister, Saritha Kusam, Hao Wu, Ninah Clegg, Arpita Mondal, Deepali V Sawant, Alexander L Dent

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 165 citations in OpenAlex.

  1. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. HIF-1αImmunity · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. B Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond.International journal of molecular sciences · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kristin HollisterDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202.
Saritha Kusam
Hao Wu
Ninah Clegg
Arpita Mondal
Deepali V Sawant
Alexander L Dent
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · US

Funding

BASIC SCIENCE STUDIES ON GENE THERAPY OF BLOOD DISEASEST32HL007910 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Roland W. Herzog, Reuben Kapur · 1999 to 2026
$7.6M
Immunology and Infectious Diseases Training ProgramT32AI060519 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARK H KAPLAN · 2004 to 2026
$6.0M
Control of autoimmunity by follicular helper T cells and BCL6R21AI090150 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI DENT, ALEXANDER L · 2010 to 2011
$421k
Development of follicular helper T cell deficient miceR21AI099825 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI DENT, ALEXANDER L · 2012 to 2013
$415k
Control of airway inflammation and Th2 differentiation by microRNA 21R56AI097607 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI DENT, ALEXANDER L · 2012 to 2012
$193k
NHLBI NIH HHS T32 HL007910NHLBI NIH HHS T32 HL007910-14NIAID NIH HHS 1R21AI090150NIAID NIH HHS 1R21AI092212NIAID NIH HHS 1R21AI099825NIAID NIH HHS R21 AI090150NIAID NIH HHS R21 AI099825NIAID NIH HHS R56 AI097607NIAID NIH HHS T32 AI060519
6 · The paper itself

Abstract

The transcriptional repressor Bcl6 controls development of the follicular Th cell (T(FH)) lineage, but the precise mechanisms by which Bcl6 regulates this process are unclear. A model has been proposed whereby Bcl6 represses the differentiation of T cells into alternative effector lineages, thus favoring T(FH) cell differentiation. Analysis of T cell differentiation using Bcl6-deficient mice has been complicated by the strong proinflammatory phenotype of Bcl6-deficient myeloid cells. In this study, we report data from a novel mouse model where Bcl6 is conditionally deleted in T cells (Bcl6(fl/fl)Cre(CD4) mice). After immunization, programmed death -1 (PD-1)(high) T(FH) cells in Bcl6(fl/fl)Cre(CD4) mice are decreased >90% compared with control mice, and Ag-specific IgG is sharply reduced. Residual PD-1(high)CXCR5(+) T(FH) cells in Bcl6(fl/fl)Cre(CD4) mice show a significantly higher rate of apoptosis than do PD-1(high)CXCR5(+) T(FH) cells in control mice. Immunization of Bcl6(fl/fl)Cre(CD4) mice did not reveal enhanced differentiation into Th1, Th2, or Th17 lineages, although IL-10 expression by CD4 T cells was markedly elevated. Thus, T cell-extrinsic factors appear to promote the increased Th1, Th2, and Th17 responses in germline Bcl6-deficient mice. Furthermore, IL-10 may be a key target gene for Bcl6 in CD4 T cells, which enables Bcl6 to promote the T(FH) cell phenotype. Finally, our data reveal a novel mechanism for the role of Bcl6 in promoting T(FH) cell survival.

Indexed as

MutationAnimalsB-Lymphocyte SubsetsCell DifferentiationCell SurvivalDNA-Binding ProteinsGene ExpressionGene Knockout TechniquesGene OrderGene TargetingGerminal CenterInterleukin-10MiceMice, TransgenicProto-Oncogene Proteins c-bcl-6T-Lymphocytes, Helper-InducerBcl6 protein, mouseDNA-Binding ProteinsInterleukin-10Proto-Oncogene Proteins c-bcl-6

Identifiers

PMID23980208
PMCPMC3783642
OpenAlexW2143253904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.